Back to search

Article

Integrating Genetic and Immune Profiles for Personalized Immunotherapy in Alzheimer’s Disease

2025-01-13

Abstract excerpt

Alzheimer's disease is the leading cause of dementia worldwide, with the number of patients expected to reach 131 million by 2050. Current treatments can only alleviate the symptoms of AD and are unable to halt the progression of the disease. Personalized immunotherapy shows great potential, as it can improve treatment efficacy and reduce side effects through precise targeting and early intervention. This pap...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5eda059e-5476-57de-abfd-138e24203672
DOI
10.20944/preprints202501.0858.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Integrating Genetic and Immune Profiles for Personalized Immunotherapy in Alzheimer’s DiseaseDOI 10.20944/preprints202501.0858.v1
Select a neighboring publication to make it the new centre.